Loading...
XSHE
002901
Market cap2.74bUSD
Jul 10, Last price  
44.76CNY
1D
-0.47%
1Q
3.28%
IPO
154.67%
Name

Double Medical Technology Inc

Chart & Performance

D1W1MN
XSHE:002901 chart
P/E
30.90
P/S
7.13
EPS
1.45
Div Yield, %
1.11%
Shrs. gr., 5y
0.32%
Rev. gr., 5y
10.39%
Revenues
2.60b
+21.79%
202,655,000298,891,503391,825,236462,663,857594,014,624772,469,5281,257,317,9981,586,860,2081,994,333,8241,434,099,1791,533,121,2812,135,559,3702,600,859,747
Net income
600m
+68.06%
96,812,000139,289,568188,666,028219,328,247295,556,292371,453,097465,490,903605,684,145673,309,41592,555,27958,960,616356,803,432599,631,709
CFO
831m
+87.96%
106,507,000151,117,000123,443,000207,128,000308,700,000334,876,000433,877,000555,770,000673,262,000128,445,00073,892,000442,300,000831,337,037
Dividend
May 30, 20250.5 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Double Medical Technology Inc. is a medical enterprise offering a diverse array of services, advanced technologies, and specialized devices. Primarily serving the Chinese market, its core competencies lie in orthopedics, wound management, neurosurgery, and general surgical solutions. The company also boasts an international footprint, distributing its products to approximately 50 countries and regions worldwide, including the European Union, Russia, South America, Australia, Southeast Asia, the Middle East, and South Africa. Founded in 2004 under its previous name, Xiamen Da Bo Ying Jing Medical Equipment Company Limited, Double Medical Technology Inc. is headquartered in Xiamen, People's Republic of China.
IPO date
Sep 22, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT